Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
A team of chemists from the US and Germany has mapped a molecular mechanism that underpins the formation of cataracts - the world's leading cause of blindness, affecting nearly 20 million people.
The scientists hope their groundbreaking discovery will lead to treatments that could help prevent the condition.
"That's the dream," says one team member, Rachel Martin, associate professor of chemistry at University of California (UC) Irvine, who describes the study - which appears on the December cover of the journal Structure - as "a big step" and explains:
"Understanding the molecular mechanism of what goes wrong in the eye that leads to a cataract could lead to the development of better treatment options, including more sophisticated artificial lenses and drugs."
Scientists had already established that our lenses are able to focus while maintaining transparency because of a delicate balance played by three kinds of crystallin protein.
Two of the proteins are structural, while a third, dubbed the "chaperone," stops the others from clumping, which can happen if they undergo genetic mutation or become damaged by chemicals or ultraviolet light.
To try to discover which molecular mechanisms might underpin this delicate balance, the researchers explored the structures of the normal proteins and a genetic mutation that is known to cause cataracts in young children.
They discovered that when the mutated protein is present, chaperone proteins work extra hard to bind strongly to the faulty protein to keep the lens transparent.
This sounds like a very good system, but the team discovered a major problem - the human eye does not have an endless supply of chaperone proteins and once they are used up, the other proteins begin to aggregate and cloud up the lens.
By mapping the molecular pathways through which these various processes happen, the team hopes organic chemists will be able to use them as a starting point for developing ways to prevent the proteins from clumping.
Some may wonder why this is considered so important, as there are excellent procedures now for treating cataracts with laser surgery and other options.
But, as the World Health Organization has shown, there are millions of people who still lose their sight through cataracts because they have no access to these corrective techniques. And these numbers are set to escalate over the next few years, especially in India, China, Southeast Asia and the Eastern Mediterranean regions.
Grants from the National Institutes of Health the Deutsche Forschungsgemeinschaft helped fund the study.
Earlier this year, researchers analyzing US military health care data found that statin use may raise cataract risk.
Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Preferential and Specific Binding of Human αB-Crystallin to a Cataract-Related Variant of γS-Crystallin; Carolyn N. Kingsley, William D. Brubaker, Stefan Markovic, Anne Diehl, Amanda J. Brindley, Hartmut Oschkinat, Rachel W. Martin; Structure 21(12) pp. 2221 - 2227, 3 December 2013; DOI: 10.1016/j.str.2013.09.017; Abstract.
Additional source: UC Irvine news release 5 December 2013.
Visit our Eye Health / Blindness category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Paddock, Catharine. "Chemists map molecular process of cataracts." Medical News Today. MediLexicon, Intl., 6 Dec. 2013. Web.
24 Apr. 2014. <http://www.medicalnewstoday.com/articles/269776>
Paddock, C. (2013, December 6). "Chemists map molecular process of cataracts." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/269776.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.